253 related articles for article (PubMed ID: 24392714)
1. Interactions between valproic acid and quetiapine/olanzapine in the treatment of bipolar disorder and the role of therapeutic drug monitoring.
Vella T; Mifsud J
J Pharm Pharmacol; 2014 Jun; 66(6):747-59. PubMed ID: 24392714
[TBL] [Abstract][Full Text] [Related]
2. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
Calabrese JR; Elhaj O; Gajwani P; Gao K
J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
[TBL] [Abstract][Full Text] [Related]
3. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Jing Y; Kim E; You M; Pikalov A; Tran QV
J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
[TBL] [Abstract][Full Text] [Related]
4. Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder.
Bhalerao S; Seyfried LS; Kim HM; Chiang C; Kavanagh J; Kales HC
J Geriatr Psychiatry Neurol; 2012 Mar; 25(1):29-36. PubMed ID: 22467844
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive risperidone, olanzapine and quetiapine for the treatment of hospitalized patients with bipolar I disorder: a retrospective study.
Pae CU; Nassir Ghaemi S; Patkar A; Chae JH; Bahk WM; Jun TY; Masand P
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1322-5. PubMed ID: 16631294
[TBL] [Abstract][Full Text] [Related]
6. New treatments for bipolar disorder: the role of atypical neuroleptic agents.
Ghaemi SN
J Clin Psychiatry; 2000; 61 Suppl 14():33-42. PubMed ID: 11154015
[TBL] [Abstract][Full Text] [Related]
7. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.
Yatham LN; Kennedy SH; O'Donovan C; Parikh SV; MacQueen G; McIntyre RS; Sharma V; Beaulieu S;
Bipolar Disord; 2006 Dec; 8(6):721-39. PubMed ID: 17156158
[TBL] [Abstract][Full Text] [Related]
8. Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
Perlis RH
Am J Manag Care; 2007 Nov; 13(7 Suppl):S178-88. PubMed ID: 18041879
[TBL] [Abstract][Full Text] [Related]
9. Atypical antipsychotics related metabolic syndrome in bipolar patients.
Yumru M; Savas HA; Kurt E; Kaya MC; Selek S; Savas E; Oral ET; Atagun I
J Affect Disord; 2007 Mar; 98(3):247-52. PubMed ID: 16970993
[TBL] [Abstract][Full Text] [Related]
10. Revised Korean medication algorithm for bipolar disorder.
Jon DI; Bahk WM; Yoon BH; Shin YC; Cho HS; Lee E; Ha K; Kim W; Chung SK; Seo JS; Min KJ
World J Biol Psychiatry; 2009; 10(4 Pt 3):846-55. PubMed ID: 18615367
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic drug-drug interactions between olanzapine and valproate need to be better studied.
de Leon J; Diaz FJ; Spina E
J Clin Psychiatry; 2010 Jul; 71(7):957-8; author reply 958-9. PubMed ID: 20667295
[No Abstract] [Full Text] [Related]
12. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
13. Hyperammonemia induced by interaction of valproate and quetiapine.
Halaby A; Haddad R; Naja WJ
Curr Drug Saf; 2013 Sep; 8(4):284-6. PubMed ID: 23962184
[TBL] [Abstract][Full Text] [Related]
14. Combination treatment with quetiapine in bipolar disorder patients.
Basu D; Chakraborty K
Am J Psychiatry; 2009 Oct; 166(10):1185; author reply 1186-7. PubMed ID: 19797447
[No Abstract] [Full Text] [Related]
15. Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics.
Dikeos D; Badr MG; Yang F; Pesek MB; Fábián Z; Tapia-Paniagua G; Hudiţă C; Okasha T; D'yachkova Y; Harrison G; Treuer T
World J Biol Psychiatry; 2010 Jun; 11(4):667-76. PubMed ID: 20334575
[TBL] [Abstract][Full Text] [Related]
16. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
Winter HR; DeVane CL; Figueroa C; Ennis DJ; Hamer-Maansson JE; Davis PC; Smith MA
Hum Psychopharmacol; 2007 Oct; 22(7):469-76. PubMed ID: 17729385
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E
Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254
[TBL] [Abstract][Full Text] [Related]
18. Reversible parkinsonism and cognitive decline due to a possible interaction of valproic acid and quetiapine.
De Dios C; Fudio S; Lorenzo A
J Clin Pharm Ther; 2011 Jun; 36(3):430-2. PubMed ID: 21545624
[TBL] [Abstract][Full Text] [Related]
19. Treatment of bipolar depression: making sensible decisions.
Citrome L
CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
[TBL] [Abstract][Full Text] [Related]
20. Long-term use of atypical antipsychotics in bipolar disorder.
Ehret MJ; Levin GM
Pharmacotherapy; 2006 Aug; 26(8):1134-47. PubMed ID: 16863489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]